glatiramer acetate
Commercial- Indications
- Multiple sclerosis
Company intelligence / Profile preview
Apicore manufactures over 100 different APIs, including over 35 for which Drug Master Files have been submitted to the FDA and 12 that are approved for commercial sale in the U.S.[3]
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apicore LLC.